Your browser doesn't support javascript.
loading
Crosstalk between gut-brain axis: unveiling the mysteries of gut ROS in progression of Parkinson's disease.
Soni, Divya; Upadhayay, Shubham; Dhureja, Maanvi; Arthur, Richmond; Kumar, Puneet.
Affiliation
  • Soni D; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India.
  • Upadhayay S; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India.
  • Dhureja M; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India.
  • Arthur R; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India.
  • Kumar P; Department of Pharmacology, Central University of Punjab, Ghudda, Bathinda, 151401, Punjab, India. punnubansal79@gmail.com.
Inflammopharmacology ; 2024 Jul 11.
Article in En | MEDLINE | ID: mdl-38992324
ABSTRACT
"Path to a good mood lies through the gut." This statement seems to imply that it has long been believed that the gut is connected with the brain. Research has shown that eating food activates the reward system and releases dopamine (DA), establishing a link between the peripheral and central nervous system. At the same time, researchers also trust that the gut is involved in the onset of many diseases, including Parkinson's disease (PD), in which gastrointestinal dysfunction is considered a prevalent symptom. Reports suggest that PD starts from the gut and reaches the brain via the vagus nerve. Recent studies have revealed an intriguing interaction between the gut and brain, which links gut dysbiosis to the etiology of PD. This review aims to explore the mechanistic pathway how reactive oxygen species (ROS) generation in the gut affects the makeup and operation of the dopamine circuitry in the brain. Our primary concern is ROS generation in the gut, which disrupts the gut microbiome (GM), causing α-synuclein accumulation and inflammation. This trio contributes to the loss of DA neurons in the brain, resulting in PD development. This review also compiles pre-clinical and clinical studies on antioxidants, demonstrating that antioxidants reduce ROS and increase DA levels. Collectively, the study highlights the necessity of comprehending the gut-brain axis for unraveling the riddles of PD pathogenesis and considering new therapeutic approaches.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Inflammopharmacology Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Inflammopharmacology Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Affiliation country: India